Literature DB >> 8006720

Influence of galactooligosaccharides on the human fecal microflora.

M Ito1, Y Deguchi, K Matsumoto, M Kimura, N Onodera, T Yajima.   

Abstract

The effects of galactooligosaccharides intake on fecal microflora and their metabolism were investigated in twelve healthy volunteers, in whom the numbers of indigenous bifidobacteria are comparatively low. The galactooligosaccharides ingestion increased the number of bifidobacteria, but remarkable changes of other organisms were not observed. This sugar also lowered fecal nitroreductase activity, the concentrations of indole and isovaleric acid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8006720     DOI: 10.3177/jnsv.39.635

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  13 in total

1.  Complex-oligosaccharide composed of galacto-oligosaccharide and lactulose ameliorates loperamide-induced constipation in rats.

Authors:  Jung Il Kwon; Yooheon Park; Dong Ouk Noh; Hyung Joo Suh; Sung Hee Han
Journal:  Food Sci Biotechnol       Date:  2018-01-05       Impact factor: 2.391

2.  Characterization of a novel beta-galactosidase from Bifidobacterium adolescentis DSM 20083 active towards transgalactooligosaccharides.

Authors:  K M Van Laere; T Abee; H A Schols; G Beldman; A G Voragen
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

3.  Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides.

Authors:  Alberto Amaretti; Tatiana Bernardi; Elena Tamburini; Simona Zanoni; Mariella Lomma; Diego Matteuzzi; Maddalena Rossi
Journal:  Appl Environ Microbiol       Date:  2007-04-13       Impact factor: 4.792

4.  Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.

Authors:  Kentaro Shimizu; Hiroshi Ogura; Miki Goto; Takashi Asahara; Koji Nomoto; Masami Morotomi; Asako Matsushima; Osamu Tasaki; Kieko Fujita; Hideo Hosotsubo; Yasuyuki Kuwagata; Hiroshi Tanaka; Takeshi Shimazu; Hisashi Sugimoto
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

5.  Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans.

Authors:  Lauren M G Davis; Inés Martínez; Jens Walter; Caitlin Goin; Robert W Hutkins
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

Review 6.  Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.

Authors:  Aleksandra Duda-Chodak; Tomasz Tarko; Paweł Satora; Paweł Sroka
Journal:  Eur J Nutr       Date:  2015-02-12       Impact factor: 5.614

Review 7.  Implication of fructans in health: immunomodulatory and antioxidant mechanisms.

Authors:  Elena Franco-Robles; Mercedes G López
Journal:  ScientificWorldJournal       Date:  2015-03-16

Review 8.  Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective.

Authors:  Kentaro Shimizu; Hiroshi Ogura; Takashi Asahara; Koji Nomoto; Masami Morotomi; Osamu Tasaki; Asako Matsushima; Yasuyuki Kuwagata; Takeshi Shimazu; Hisashi Sugimoto
Journal:  Dig Dis Sci       Date:  2012-08-19       Impact factor: 3.199

9.  Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.

Authors:  Megan Rossi; Kerenaftali Klein; David W Johnson; Katrina L Campbell
Journal:  Int J Nephrol       Date:  2012-12-19

10.  Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Serge Rezzi; Ziad Ramadan; Emma Peré-Trepat; Florence Rochat; Christine Cherbut; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-07-15       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.